XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 5,114 $ 8,413
Trade accounts receivable, net of allowance for doubtful accounts of $325 and $346, respectively 22,349 20,232
Inventories, net 39,201 33,189
Prepaid expenses and other current assets 5,161 4,690
Total current assets 71,825 66,524
Property, plant and equipment, net 22,338 23,205
Goodwill 37,502 38,068
Other intangible assets, net 16,566 17,390
Deferred income taxes, net 11,731 11,472
Other noncurrent assets 2,261 2,879
Total assets 162,223 159,538
Current liabilities:    
Accounts payable 13,441 9,823
Current portion of long-term debt 2,000 2,000
Accrued compensation and related benefits 1,924 1,842
Accrued expenses and other current liabilities 4,811 5,259
Total current liabilities 22,176 18,924
Long-term debt 19,566 18,857
Deferred income taxes 2,086 2,254
Other noncurrent liabilities 1,328 1,760
Total liabilities 45,156 41,795
Shareholders’ equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,560,796 shares at March 31, 2022 and 20,522,427 shares at December 31, 2021; outstanding – 16,127,082 shares at March 31, 2022 and 16,089,832 shares at December 31, 2021 2,057 2,052
Capital in excess of par value 186,999 186,518
Accumulated deficit (47,488) (47,832)
Accumulated other comprehensive loss (3,151) (1,653)
Treasury stock - at cost; 4,433,714 shares at March 31, 2022 and 4,432,595 shares at December 31, 2021 (21,480) (21,469)
Total Ultralife Corporation equity 116,937 117,616
Non-controlling interest 130 127
Total shareholders’ equity 117,067 117,743
Total liabilities and shareholders’ equity $ 162,223 $ 159,538